Effect of valsartan-eluting stents on the expression of angiotensin II type 2 receptor.
Wang
Lei
L
Cardiovascular Center of Beijing Friendship Hospital, Capital University of Medicine Sciences, Beijing 100050, China. wanglei@china.com
Li
Gui-hua
GH
Chen
Hui
H
Li
Hong-wei
HW
Zhao
Lin
L
Yao
Dao-kuo
DK
Ding
Rong-jing
RJ
Jia
San-qing
SQ
D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage*; D000818:Animals; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000517:prevention & control; D003331:Coronary Vessels / Q000473:pathology; D016503:Drug Delivery Systems; D007150:Immunohistochemistry; D011817:Rabbits; D044140:Receptor, Angiotensin, Type 1 / Q000032:analysis; D044139:Receptor, Angiotensin, Type 2 / Q000032:analysis* / Q000235:genetics / Q000502:physiology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015607:Stents; D013777:Tetrazoles / Q000008:administration & dosage*; D014633:Valine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000068756:Valsartan
D047228:Angiotensin II Type 1 Receptor Blockers; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D013777:Tetrazoles; D000068756:Valsartan; D014633:Valine